BioCentury
ARTICLE | Company News

PerSeptive enabling technology news

August 14, 1995 7:00 AM UTC

The U.S. District Court in Boston approved the settlement of class action securities litigation brought against PBIO and certain officers in December 1994. As approved, PBIO is responsible for $9 million of the $12 million settlement.

According to Noubar Afeyan, president and CEO, PBIO will pay $2 million in warrants, $5 million in common stock and $2 million in cash. Afeyan said the cash is largely due in 1996. PBIO's insurers and other parties are responsible for $3 million. Prior to the settlement, the Framingham, Mass., company has 12.5 million shares outstanding. ...